2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-cyclohexylacetamide

C20H28N4O — CID 16810436

IUPAC2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-cyclohexylacetamide
SMILESO=C(CN1CCC(c2nc3ccccc3[nH]2)CC1)NC1CCCCC1
InChIInChI=1S/C20H28N4O/c25-19(21-16-6-2-1-3-7-16)14-24-12-10-15(11-13-24)20-22-17-8-4-5-9-18(17)23-20/h4-5,8-9,15-16H,1-3,6-7,10-14H2,(H,21,25)(H,22,23)
InChIKeyBLYWUYKZVMOKAV-UHFFFAOYSA-N
MW340.47 g/mol
LogP3.19
Rot. Bonds4

About 2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-cyclohexylacetamide

2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-cyclohexylacetamide (PubChem CID 16810436) has the molecular formula C20H28N4O and a molecular weight of 340.47 g/mol. Its IUPAC name is 2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-cyclohexylacetamide.

Molecular Properties

Compound Name2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-cyclohexylacetamide
PubChem CID16810436
Molecular FormulaC20H28N4O
Molecular Weight340.47 g/mol
Exact Mass340.23
IUPAC Name2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-cyclohexylacetamide
SMILESO=C(CN1CCC(c2nc3ccccc3[nH]2)CC1)NC1CCCCC1
InChIInChI=1S/C20H28N4O/c25-19(21-16-6-2-1-3-7-16)14-24-12-10-15(11-13-24)20-22-17-8-4-5-9-18(17)23-20/h4-5,8-9,15-16H,1-3,6-7,10-14H2,(H,21,25)(H,22,23)
InChIKeyBLYWUYKZVMOKAV-UHFFFAOYSA-N
XLogP3.19
TPSA61.02 Ų
H-Bond Donors2
H-Bond Acceptors3
Rotatable Bonds4
Heavy Atoms25
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500340.47
LogP ≤ 53.19
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 103

Analyze 2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-cyclohexylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-cyclopentylacetamide
CID 16810435
2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-(oxolan-2-ylmethyl)acetamide
CID 16810440
2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-(4-pyrrolidin-1-ylphenyl)acetamide
CID 1436961
N-cyclohexyl-2-(4-pyridin-2-ylpiperidin-1-yl)acetamide
CID 68873162
2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-(2-morpholin-4-ylphenyl)acetamide
CID 1436952
2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-(2,3-dihydro-1,4-benzodioxin-6-yl)acetamide
CID 1429947
2-(1H-benzimidazol-2-yl)-4-benzyl-N-cyclohexylpiperazine-1-carboxamide
CID 44783424
1-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-2-cyclohexyloxyethanone
CID 56814068
2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-[2-chloro-5-(trifluoromethyl)phenyl]acetamide
CID 1453375
3-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]propan-1-ol
CID 111112410
1-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-3-cyclopentylpropan-1-one
CID 33117135
2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-(2-methoxy-4-nitrophenyl)acetamide
CID 3223449

Frequently Asked Questions

What is the IUPAC name of 2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-cyclohexylacetamide?
The IUPAC name of 2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-cyclohexylacetamide (CID 16810436) is 2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-cyclohexylacetamide.
What is the SMILES notation for 2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-cyclohexylacetamide?
The canonical SMILES for 2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-cyclohexylacetamide is O=C(CN1CCC(c2nc3ccccc3[nH]2)CC1)NC1CCCCC1.
What is the InChIKey of 2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-cyclohexylacetamide?
The InChIKey is BLYWUYKZVMOKAV-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H28N4O/c25-19(21-16-6-2-1-3-7-16)14-24-12-10-15(11-13-24)20-22-17-8-4-5-9-18(17)23-20/h4-5,8-9,15-16H,1-3,6-7,10-14H2,(H,21,25)(H,22,23).
What are the key properties of 2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-cyclohexylacetamide?
2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-cyclohexylacetamide has a molecular weight of 340.47 g/mol, XLogP of 3.19, 4 rotatable bonds, 2 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-N-cyclohexylacetamide is sourced from PubChem (CID 16810436), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).